|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Operating lease right of use asset amortization | |||||
| Financing lease right of use asset amortization | |||||
| Stock-based compensation | |||||
| Accretion of discounts on available-for-sales securities | |||||
| Gain on sale of assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled contracts receivable | |||||
| Interest receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued payroll expenses | |||||
| Operating lease liability | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| CASH FROM INVESTING ACTIVITIES | |||||
| Acquisition of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Purchase of available-for-sale securities | |||||
| Maturity of available-for-sale securities | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from at-the-market sale of stock, net of commissions and expenses | |||||
| Proceeds from sale of stock | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from stock sales | |||||
| Payments of principal for financing lease | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
Loading...